Spotlight Medical, a Paris, France-based startup creating AI-driven prognosis checks, raised €6.2M in Seed funding.
The spherical was led by Kurma Companions and Heal Capital.
Led by CEO Sylvain Berlemont, Highlight Medical is a precision medication firm advancing AI checks that improve therapy choice by leveraging many years of affected person information. This ensures customized and efficient take care of every particular person, considerably bettering affected person outcomes and high quality of life.
The corporate intends to make use of the funds to carry its first prognosis check to the clinic, marking a major milestone within the commercialization of AI-based options for most cancers therapy.
FinSMEs
12/07/2024
